TNK2 and leukemia: In a previous investigation, an integrated approach involving cell-based pharmacologic screening combined with native kinase profiling, gene expression profiling, and mechanism studies, identified ACK1 and GCK kinases that synergistically contributed to the growth of NRAS transformed leukemia cells, including OCI-AML3 cells (32).